SpringerLink
Log in

WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Mutations in the WAF1/CIP1 gene were not found in 36 ovarian carcinomas, including tumours with loss of heterozygosity at the WAF1/CIP1 locus and/or lacking p53 mutations. In addition, no association was demonstrable between a polymorphism in a conserved region of the WAF1/CIP1 gene and ovarian carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Pathology, Kenneth Norris Jr. Comprehensive Cancer Center, Los Angeles, 90033, CA, USA

    M Wan

Authors
  1. M Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. KF Cofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Dubeau
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wan, M., Cofer, K. & Dubeau, L. WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer. Br J Cancer 73, 1398–1400 (1996). https://doi.org/10.1038/bjc.1996.265

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1996.265

  • Springer Nature Limited

This article is cited by

Search

Navigation